What You Should Know:
- Veeva Systems has announced a new collaboration with Amgen, a global leader in biotechnology, to advance clinical trial innovation.
- Amgen will use the Veeva Clinical Platform to find and implement efficiencies across its clinical trial processes.
Connected Platform for Clinical Development
The Veeva Clinical Platform is a complete and connected platform that covers clinical operations and data applications. This end-to-end platform includes
Read More
Reach7 Diabetes Studios and Trileas Partner to Launch CARES Program for At-Risk Communities
What You Should Know:
- Reach7 Diabetes Studios has announced that Trileas is the first official sponsor and founding member of its CARES Program. The program is a third-party sponsored initiative that provides screenings for high-risk individuals and subsidized memberships for those most in need.
- The partnership with Trileas, a company dedicated to delivering affordable connectivity and healthcare solutions, will help the CARES Program reach further, expand access, and transform
Read More
Artisight Launches AI Platform to Autonomously Document Operating Room Activity into EHRs
What You Should Know:
- Artisight, a Smart Hospital platform, has announced a new capability that autonomously documents operating room (OR) activity into a patient's electronic health record (EHR) using advanced AI and computer vision.
- This eliminates the need for clinicians and other healthcare staff to manually document key milestones in a procedure. This technology not only provides real-time updates that boost patient satisfaction but also makes a more productive use of high-demand
Read More
Former FDA Chief Counsel Joins Plan A™ to Launch Male Birth Control
What You Should Know:
- NEXT Life Sciences, a modern reproductive healthcare company, has announced that Peter Barton Hutt, a renowned FDA regulatory expert, has joined its advisory board. Known as the "Father of Modern Drug Law," Hutt served as Chief Counsel at the U.S. Food & Drug Administration (FDA) and helped shape many of the policies that still govern medical devices today. His appointment strengthens an advisory board already composed of groundbreaking experts in male
Read More
Rimidi Partners with Beth Israel Deaconess Medical Center on Food as Medicine Trial
What You Should Know:
- Rimidi, a digital health company that supports healthcare providers with EHR-integrated software and connected devices, has announced its participation in the Health Care by Food (GoFreshSoutheast) Trial. The trial is managed by Beth Israel Deaconess Medical Center (BIDMC) and funded by The American Heart Association.
- The goal of the trial is to evaluate the impact of DASH-aligned grocery store delivery in reducing high blood pressure in adults.
- The
Read More
Form Health Selected for Novo Nordisk’s NovoCare® Platform to Expand Obesity Care
What You Should Know:
- Form Health, a provider of science-based obesity and cardiometabolic care, has announced its selection as a healthcare provider option on Novo Nordisk’s NovoCare® platform.
- The NovoCare® platform connects patients with trusted healthcare providers for chronic care treatment. Form Health’s inclusion will expand access to high-quality, evidence-based care delivered by trained Obesity Medicine Clinicians and Registered Dietitians.
Form Health's
Read More
Oracle Clinical One Data Collection Enhanced with AI and EHR Integration
What You Should Know:
- Oracle has introduced significant advancements to its Electronic Data Capture (EDC) solution, Oracle Clinical One Data Collection. These new capabilities are designed to simplify clinical workflows and eliminate data friction across systems, which helps accelerate research, improve safety reporting, and bring new therapies to market faster.
- The updates, developed in collaboration with pharmaceutical industry leaders and Oracle's CRO Growth Network collaborators,
Read More
Eli Lilly’s Oral GLP-1 Orforglipron Successful in Third Phase 3 Trial
What You Should Know:
- Eli Lilly and Company has announced positive topline results from its Phase 3 ATTAIN-2 trial, which evaluated orforglipron, an investigational oral GLP-1 receptor agonist, in adults with obesity or overweight and type 2 diabetes.
- All three doses of the drug met the primary and all key secondary endpoints, showing significant weight loss, meaningful A1C reductions, and improvements in cardiometabolic risk factors over 72 weeks.
Significant Weight Loss and
Read More
Carna Health & Siemens Healthineers Partner to Advance AI-Powered CKD Screening
What You Should Know:
- Carna Health, a digital health company focused on kidney care, has announced a strategic agreement with Siemens Healthineers. The collaboration aims to accelerate the adoption of Carna's AI-enabled chronic kidney disease (CKD) platform and bring point-of-care testing systems to emerging markets.
- This will help improve early detection and CKD management for high-risk and underserved populations by integrating Carna Health’s digital platforms with Siemens
Read More
American Heart Association Launches Virtual Care Program to Reduce Heart Failure Readmissions
What You Should Know:
- With chronic disease rates rising and nearly one in four heart failure patients readmitted to the hospital within 30 days of discharge, healthcare systems face ongoing challenges in reducing hospital stays and readmissions. To address this critical gap, the American Heart Association has launched American Heart Association Connected Care™, Powered by Cadence. This new virtual care program delivers ongoing heart and cardiometabolic care to patients at home after their
Read More
